Daniel Razansky,Sandeep Kumar Kalva,Vipul Gujrati et al.
Daniel Razansky et al.
This chapter explores how medical imaging has evolved beyond simple visual observation to include advanced optical technologies for disease detection. Traditionally, clinicians relied heavily on human vision, either directly or through vide...
Ultrasound Imaging [0.03%]
超声波成像
Georg Schmitz,Stefanie Dencks
Georg Schmitz
Ultrasound imaging has played an important role in oncological imaging for more than five decades now. It can be applied in all tissues that are not occluded by bone or gas-filled regions. The quality of ultrasound images benefitted strongl...
Total Body PET [0.03%]
全身PET扫描
Laura Providência,Charalampos Tsoumpas,Adriaan A Lammertsma
Laura Providência
Total body PET, or long axial field-of-view PET, is a PET scanner with an extended axial coverage compared with conventional PET scanners. The significant gain in sensitivity of these systems enables shorter scanning times, delayed imaging ...
Teresa Lemainque,Nicolas Gross-Weege,Volkmar Schulz
Teresa Lemainque
SPECT and PET are nuclear tomographic imaging modalities that visualize functional information based on the accumulation of radioactive tracer molecules. However, SPECT and PET lack anatomical information, which has motivated their combinat...
Morgan McLaughlin,Marcel van Straten,Esther A H Warnert et al.
Morgan McLaughlin et al.
Imaging in Oncology is rapidly moving from the detection and size measurement of a lesion to the quantitative assessment of metabolic processes and cellular and molecular interactions. Increasing insights into cancer as a complex disease wi...
Daniela Pfeiffer,Ernst Rummeny,Franz Pfeiffer
Daniela Pfeiffer
Since their discovery by Wilhelm Conrad Röntgen in 1895, X-rays have become the most widely available, typically fastest, and usually most cost-effective medical imaging modality today. From the early radiographic approaches using X-ray fi...
Marco Ruiz Santillan,Ramona Dadu,Robert F Gagel et al.
Marco Ruiz Santillan et al.
Medullary thyroid carcinoma (MTC) is a rare disease that is indolent in the majority of patients. In a subset of patients, the cancer is more aggressive with symptomatic or progressive disease metastasizing to cervical neck structures, lung...
Friedhelm Raue,Karin Frank-Raue
Friedhelm Raue
After surgery, patients with MTC (medullary thyroid carcinoma) should be assessed for the presence of residual disease, the localization of metastases, and the identification of progressive disease. Postoperative staging is used to separate...
Andreas Machens,Henning Dralle
Andreas Machens
Medullary thyroid cancer (MTC) is an infrequent calcitonin-secreting thyroid malignancy that can vary a great deal in tumor biology and progression. The most important determinant of distant metastases, which represents the single greatest ...
Katerina Saltiki,Maria Alevizaki
Katerina Saltiki
One of the components of the classical form of MEN2 syndromes is primary hyperparathyroidism (PHP). It occurs in 20-30% of the typical MEN2A syndrome. Recently, the prevalence in ret gene carriers is rarer possibly due to the increased reco...